Eutropics Pharmaceuticals
PrivateLast Round
Early Stage
VC
Jan 11, 2024
Total Funding Raised
$10.6M
Company Overview
Eutropics Pharmaceuticals is a biotechnology company that develops predictive diagnostic biomarker technology designed to guide cancer treatment decisions by measuring protein-protein interactions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eutropics Pharmaceuticals Comparables
Compare Eutropics Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kiyatec | 85% | |
| Travera | 84% | |
| SageMedic Corp. | 83% | |
Eutropics Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jan 11, 2024 | ||||
| Grant | Aug 27, 2019 | ||||
| Grant | Jun 1, 2019 | ||||
| Grant | Sep 1, 2018 | ||||
| Grant | Sep 1, 2017 | ||||
Grant | Sep 18, 2012 |
Eutropics Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| MassVentures | Grant |
| Massachusetts Life Sciences Center | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 11, 2024
Raised an early stage VC round.
- Aug 27, 2019
$1.5M grant awarded by the National Cancer Institute.
Eutropics Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eutropics Pharmaceuticals's valuation, stock price, and market status.